Literature DB >> 27927619

Bias Due to Correlation Between Times-at-Risk for Infection in Epidemiologic Studies Measuring Biological Interactions Between Sexually Transmitted Infections: A Case Study Using Human Papillomavirus Type Interactions.

Talía Malagón, Philippe Lemieux-Mellouki, Jean-François Laprise, Marc Brisson.   

Abstract

The clustering of human papillomavirus (HPV) infections in some individuals is often interpreted as the result of common risk factors rather than biological interactions between different types of HPV. The intraindividual correlation between times-at-risk for all HPV infections is not generally considered in the analysis of epidemiologic studies. We used a deterministic transmission model to simulate cross-sectional and prospective epidemiologic studies measuring associations between 2 HPV types. When we assumed no interactions, the model predicted that studies would estimate odds ratios and incidence rate ratios greater than 1 between HPV types even after complete adjustment for sexual behavior. We demonstrated that this residual association is due to correlation between the times-at-risk for different HPV types, where individuals become concurrently at risk for all of their partners' HPV types when they enter a partnership and are not at risk when they are single. This correlation can be controlled in prospective studies by restricting analyses to susceptible individuals with an infected sexual partner. The bias in the measured associations was largest in low-sexual-activity populations, cross-sectional studies, and studies which evaluated infection with a first HPV type as the exposure. These results suggest that current epidemiologic evidence does not preclude the existence of competitive biological interactions between HPV types.
© The Author 2016. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  bias (epidemiology); coinfection; cross-protection; microbial interactions; papillomavirus infections; sexually transmitted diseases; time factors; viral interference

Mesh:

Year:  2016        PMID: 27927619      PMCID: PMC5161088          DOI: 10.1093/aje/kww152

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  55 in total

1.  Incidence, duration, and reappearance of type-specific cervical human papillomavirus infections in young women.

Authors:  Ralph P Insinga; Gonzalo Perez; Cosette M Wheeler; Laura A Koutsky; Suzanne M Garland; Sepp Leodolter; Elmar A Joura; Daron G Ferris; Marc Steben; Darron R Brown; Elamin H Elbasha; Jorma Paavonen; Richard M Haupt
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-06       Impact factor: 4.254

2.  Sexual behavior, sexual attraction, and sexual identity in the United States: data from the 2006-2008 National Survey of Family Growth.

Authors:  Anjani Chandra; William D Mosher; Casey Copen; Catlainn Sionean
Journal:  Natl Health Stat Report       Date:  2011-03-03

3.  Prevalence and clustering patterns of human papillomavirus genotypes in multiple infections.

Authors:  Anil K Chaturvedi; Leann Myers; Ansley F Hammons; Rebecca A Clark; Kathleen Dunlap; Patricia J Kissinger; Michael E Hagensee
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-10       Impact factor: 4.254

Review 4.  Pathogen-pathogen interaction: a syndemic model of complex biosocial processes in disease.

Authors:  Merrill Singer
Journal:  Virulence       Date:  2010 Jan-Feb       Impact factor: 5.882

5.  A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types.

Authors:  K L Liaw; A Hildesheim; R D Burk; P Gravitt; S Wacholder; M M Manos; D R Scott; M E Sherman; R J Kurman; A G Glass; S M Anderson; M Schiffman
Journal:  J Infect Dis       Date:  2000-11-16       Impact factor: 5.226

6.  The role of sexual behavior and human papillomavirus persistence in predicting repeated infections with new human papillomavirus types.

Authors:  Anna-Barbara Moscicki; Yifei Ma; Janet Jonte; Susanna Miller-Benningfield; Evelyn Hanson; Julie Jay; Cheryl Godwin de Medina; Sepideh Farhat; Lisa Clayton; Stephen Shiboski
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-08       Impact factor: 4.254

7.  Distribution of human papillomavirus types, cervical cancer screening history, and risk factors for infection in Manitoba.

Authors:  A A Demers; B Shearer; A Severini; R Lotocki; E V Kliewer; S Stopera; T Wong; G Jayaraman
Journal:  Chronic Dis Inj Can       Date:  2012-09

8.  Causal inference in infectious diseases.

Authors:  M E Halloran; C J Struchiner
Journal:  Epidemiology       Date:  1995-03       Impact factor: 4.822

Review 9.  Contribution of sexually transmitted infections to the sexual transmission of HIV.

Authors:  Helen Ward; Minttu Rönn
Journal:  Curr Opin HIV AIDS       Date:  2010-07       Impact factor: 4.283

10.  Sexual risk factors for HIV infection in early and advanced HIV epidemics in sub-Saharan Africa: systematic overview of 68 epidemiological studies.

Authors:  Li Chen; Prabhat Jha; Bridget Stirling; Sema K Sgaier; Tina Daid; Rupert Kaul; Nico Nagelkerke
Journal:  PLoS One       Date:  2007-10-03       Impact factor: 3.240

View more
  8 in total

1.  Recurring infection with ecologically distinct HPV types can explain high prevalence and diversity.

Authors:  Sylvia L Ranjeva; Edward B Baskerville; Vanja Dukic; Luisa L Villa; Eduardo Lazcano-Ponce; Anna R Giuliano; Greg Dwyer; Sarah Cobey
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-05       Impact factor: 11.205

2.  Capturing multiple-type interactions into practical predictors of type replacement following human papillomavirus vaccination.

Authors:  Irene Man; Kari Auranen; Jacco Wallinga; Johannes A Bogaards
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-27       Impact factor: 6.237

3.  Coinfections by noninteracting pathogens are not independent and require new tests of interaction.

Authors:  Frédéric M Hamelin; Linda J S Allen; Vrushali A Bokil; Louis J Gross; Frank M Hilker; Michael J Jeger; Carrie A Manore; Alison G Power; Megan A Rúa; Nik J Cunniffe
Journal:  PLoS Biol       Date:  2019-12-03       Impact factor: 8.029

Review 4.  Effect of HSV-2 infection on subsequent HIV acquisition: an updated systematic review and meta-analysis.

Authors:  Katharine J Looker; Jocelyn A R Elmes; Sami L Gottlieb; Joshua T Schiffer; Peter Vickerman; Katherine M E Turner; Marie-Claude Boily
Journal:  Lancet Infect Dis       Date:  2017-08-23       Impact factor: 71.421

5.  Evidence of synergistic relationships between HIV and Human Papillomavirus (HPV): systematic reviews and meta-analyses of longitudinal studies of HPV acquisition and clearance by HIV status, and of HIV acquisition by HPV status.

Authors:  Katharine J Looker; Minttu M Rönn; Patrick M Brock; Marc Brisson; Melanie Drolet; Philippe Mayaud; Marie-Claude Boily
Journal:  J Int AIDS Soc       Date:  2018-06       Impact factor: 5.396

6.  Detecting within-host interactions from genotype combination prevalence data.

Authors:  Samuel Alizon; Carmen Lía Murall; Emma Saulnier; Mircea T Sofonea
Journal:  Epidemics       Date:  2019-06-18       Impact factor: 4.396

7.  Concurrent Infection With Multiple Human Papillomavirus Types Among Unvaccinated and Vaccinated 17-Year-Old Norwegian Girls.

Authors:  Ida Laake; Berit Feiring; Christine Monceyron Jonassen; John H O Pettersson; Torstein Gjølgali Frengen; Ingerid Ørjansen Kirkeleite; Lill Trogstad
Journal:  J Infect Dis       Date:  2022-09-04       Impact factor: 7.759

8.  Global and regional estimates of the contribution of herpes simplex virus type 2 infection to HIV incidence: a population attributable fraction analysis using published epidemiological data.

Authors:  Katharine J Looker; Nicky J Welton; Keith M Sabin; Shona Dalal; Peter Vickerman; Katherine M E Turner; Marie-Claude Boily; Sami L Gottlieb
Journal:  Lancet Infect Dis       Date:  2019-11-18       Impact factor: 71.421

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.